{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:28Z","timestamp":1791920008602,"version":"4.3.4"},"reference-count":157,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Human African Trypanosomiasis (HAT), also known as sleeping\nsickness, and Chagas disease are neglected tropical diseases caused by Trypanosoma brucei\nand Trypanosoma cruzi, respectively. These diseases present significant challenges in treatment\ndue to the toxicity, low efficacy, and drug-resistant strains associated with current therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Cysteine proteases play vital roles in the life cycles of these parasites, making\nthem potential targets for therapeutic intervention. Natural inhibitors sourced from plants, marine\norganisms, and microorganisms show promise for developing novel therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This review surveys the potential of natural inhibitors as therapeutic agents against\nHAT and Chagas disease. It compiles PubMed and PubChem information from various studies to\nprovide an overview of their activities and characteristics, including their ability to inhibit cysteine\nproteases, modulate the host immune response, and interfere with other parasite proteins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Several natural inhibitors, such as berberine, curcumin, and tannins, have been identified\nand characterized. These inhibitors have demonstrated encouraging outcomes in both in\nvitro and in vivo experiments, indicating their potential as therapeutic agents for HAT and\nChagas disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Natural inhibitors of cysteine proteases offer a promising avenue for developing\nnovel therapies against HAT and Chagas disease. Further research is needed to identify additional\nnatural inhibitors and optimize their efficacy and safety for human use. The significance\nof this study lies in its potential to contribute to the discovery of effective, safe, and affordable\ntreatments for these neglected tropical diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673311070240807104229","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T06:08:02Z","timestamp":1724825282000},"page":"2671-2705","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["To Explore Potential Natural Inhibitors of Cysteine Proteases to Combat Human African Trypanosomiasis and Chagas Disease"],"prefix":"10.2174","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9985-3481","authenticated-orcid":true,"given":"Aloke","family":"Saha","sequence":"first","affiliation":[{"name":"Cell and Developmental Biology Special, Department of Zoology, University of Kalyani, Kalyani, Nadia,741235, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7992-3582","authenticated-orcid":true,"family":"Pushpa","sequence":"additional","affiliation":[{"name":"Cell and Developmental Biology Special, Department of Zoology, University of Kalyani, Kalyani, Nadia,741235, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2302-6189","authenticated-orcid":true,"given":"Soumya Ranjan","family":"Bagchi","sequence":"additional","affiliation":[{"name":"Disease Biology Special, Department of Zoology, University of Calcutta, Kolkata, 700019, India"},{"name":"Cytogenetics and Molecular Biology Lab, Department of Zoology, University of Kalyani, Kalyani, Nadia,741235, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3604-7404","authenticated-orcid":true,"given":"Asmita","family":"Samadder","sequence":"additional","affiliation":[{"name":"Cell and Developmental Biology Special, Department of Zoology, University of Kalyani, Kalyani, Nadia,741235, India"},{"name":"Cytogenetics and Molecular Biology Lab, Department of Zoology, University of Kalyani, Kalyani,Nadia, 741235, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9960-6584","authenticated-orcid":true,"given":"Sisir","family":"Nandi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education andResearch (Affiliated to Veer Madho Singh Bhandari Uttarakhand Technical University), Kashipur, 244713, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2023","unstructured":"Trachoma.  Available from:  https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/trypanosomiasis-human-african-(sleeping-sickness)#:~:text=Human% 20African% 20trypanosomiasis%2C%20also%20known,from%20infected%20humans%20or%20animals2023"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.3389\/fimmu.2018.02253","volume":"9","author":"Radwanska M.","year":"2018","unstructured":"Radwanska M.; Vereecke N.; Deleeuw V.; Pinto J.; Magez S.; Salivarian Trypanosomosis: A Review of Parasites Involved, Their Global Distribution and Their Interaction With the Innate and Adaptive Mammalian Host Immune System. Front Immunol  2018,9,2253","journal-title":"Front Immunol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0014-4894(70)90120-7","volume":"28","author":"Lanham S.M.","year":"1970","unstructured":"Lanham S.M.; Godfrey D.G.; Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp Parasitol  1970,28(3),521-534","journal-title":"Exp Parasitol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2307\/3274538","volume":"44","author":"McKeever S.","year":"1958","unstructured":"McKeever S.; Gorman G.W.; Norman L.; Occurrence of a Trypanosoma cruzi-like organism in some mammals from southwestern Georgia and northwestern Florida. J Parasitol  1958,44(6),583-587","journal-title":"J Parasitol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2307\/3276112","volume":"50","author":"Olsen P.F.","year":"1964","unstructured":"Olsen P.F.; Shoemaker J.P.; Turner H.F.; Hays K.L.; Incidence of Trypanosoma cruzi (Chagas) in Wild Vectors and Reservoirs in East-central Alabama. J Parasitol  1964,50(5),599-603","journal-title":"J Parasitol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1476-072X-9-57","volume":"9","author":"Simarro P.P.","year":"2010","unstructured":"Simarro P.P.; Cecchi G.; Paone M.; Franco J.R.; Diarra A.; Ruiz J.A.; F\u00e8vre E.M.; Courtin F.; Mattioli R.C.; Jannin J.G.; The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr  2010,9(1),57","journal-title":"Int J Health Geogr"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"828111","DOI":"10.3389\/fvets.2022.828111","volume":"9","author":"Kasozi K.I.","year":"2022","unstructured":"Kasozi K.I.; MacLeod E.T.; Ntulume I.; Welburn S.C.; An update on african trypanocide pharmaceutics and resistance. Front Vet Sci  2022,9,828111","journal-title":"Front Vet Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/microorganisms11061397","volume":"11","author":"Yang N.","year":"2023","unstructured":"Yang N.; Matthew M.A.; Yao C.; Roles of cysteine proteases in biology and pathogenesis of parasites. Microorganisms  2023,11(6),1397","journal-title":"Microorganisms"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fphar.2016.00107","volume":"7","author":"Verma S.","year":"2016","unstructured":"Verma S.; Dixit R.; Pandey K.C.; Cysteine proteases: Modes of activation and future prospects as pharmacological targets. Front Pharmacol  2016,7,107","journal-title":"Front Pharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e1002139","DOI":"10.1371\/journal.ppat.1002139","volume":"7","author":"Doyle P.S.","year":"2011","unstructured":"Doyle P.S.; Zhou Y.M.; Hsieh I.; Greenbaum D.C.; McKerrow J.H.; Engel J.C.; The Trypanosoma cruzi protease cruzain mediates immune evasion. PLoS Pathog  2011,7(9),e1002139","journal-title":"PLoS Pathog"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e0006512","DOI":"10.1371\/journal.pntd.0006512","volume":"12","author":"Siqueira-Neto J.L.","year":"2018","unstructured":"Siqueira-Neto J.L.; Debnath A.; McCall L.I.; Bernatchez J.A.; Ndao M.; Reed S.L.; Rosenthal P.J.; Cysteine proteases in protozoan parasites. PLoS Negl Trop Dis  2018,12(8),e0006512","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e0005850","DOI":"10.1371\/journal.pntd.0005850","volume":"12","author":"McKerrow J.H.","year":"2018","unstructured":"McKerrow J.H.; Update on drug development targeting parasite cysteine proteases. PLoS Negl Trop Dis  2018,12(8),e0005850","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"116213","DOI":"10.1016\/j.bmc.2021.116213","volume":"41","author":"Silva L.R.","year":"2021","unstructured":"Silva L.R.; Guimar\u00e3es A.S.; do Nascimento J.; do Santos Nascimento I.J.; da Silva E.B.; McKerrow J.H.; Cardoso S.H.; da Silva-J\u00fanior E.F.; Computer-aided design of 1,4-naphthoquinone-based inhibitors targeting cruzain and rhodesain cysteine proteases. Bioorg Med Chem  2021,41,116213","journal-title":"Bioorg Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"Atanasov A.G.","year":"2021","unstructured":"Atanasov A.G.; Zotchev S.B.; Dirsch V.M.; Supuran C.T.; Natural products in drug discovery: Advances and opportunities. Nat Rev Drug Discov  2021,20(3),200-216","journal-title":"Nat Rev Drug Discov"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"12771","DOI":"10.3390\/molecules171112771","volume":"17","author":"Wink M.","year":"2012","unstructured":"Wink M.; Medicinal plants: A source of anti-parasitic secondary metabolites. Molecules  2012,17(11),12771-12791","journal-title":"Molecules"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"101144","DOI":"10.1016\/j.mam.2022.101144","volume":"88","author":"\u0106wilichowska N.","year":"2022","unstructured":"\u0106wilichowska N.; \u015awiderska K.W.; Dobrzy\u0144 A.; Dr\u0105g M.; Por\u0119ba M.; Diagnostic and therapeutic potential of protease inhibition. Mol Aspects Med  2022,88,101144","journal-title":"Mol Aspects Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"14470","DOI":"10.3390\/ijms232214470","volume":"23","author":"Di Chio C.","year":"2022","unstructured":"Di Chio C.; Previti S.; De Luca F.; Bogacz M.; Zimmer C.; Wagner A.; Schirmeister T.; Zappal\u00e0 M.; Ettari R.; Drug combination studies of the dipeptide nitrile CD24 with curcumin: A new strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense. Int J Mol Sci  2022,23(22),14470","journal-title":"Int J Mol Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.3390\/ijms24108477","volume":"24","author":"Di Chio C.","year":"2023","unstructured":"Di Chio C.; Previti S.; Totaro N.; De Luca F.; Allegra A.; Schirmeister T.; Zappal\u00e0 M.; Ettari R.; Dipeptide nitrile CD34 with curcumin: A new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense. Int J Mol Sci  2023,24(10),8477","journal-title":"Int J Mol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1021\/acsmedchemlett.9b00635","volume":"11","author":"Ettari R.","year":"2020","unstructured":"Ettari R.; Previti S.; Di Chio C.; Maiorana S.; Allegra A.; Schirmeister T.; Zappal\u00e0 M.; Drug synergism: Studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense. ACS Med Chem Lett  2020,11(5),806-810","journal-title":"ACS Med Chem Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1039\/D0NP00048E","volume":"37","author":"Truax N.J.","year":"2020","unstructured":"Truax N.J.; Romo D.; Bridging the gap between natural product synthesis and drug discovery. Nat Prod Rep  2020,37(11),1436-1453","journal-title":"Nat Prod Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"9.11.1","DOI":"10.1002\/0471141755.ph0911s46","volume":"46","author":"Beutler J.A.","year":"2009","unstructured":"Beutler J.A.; Natural products as a foundation for drug discovery. CP Pharmacol  2009,46,9.11.1-9.11.21","journal-title":"CP Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"e1009866","DOI":"10.1371\/journal.ppat.1009866","volume":"17","author":"Crilly N.P.","year":"2021","unstructured":"Crilly N.P.; Mugnier M.R.; Thinking outside the blood: Perspectives on tissue-resident Trypanosoma brucei. PLoS Pathog  2021,17(9),e1009866","journal-title":"PLoS Pathog"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/jvec.12236","volume":"42","author":"Nnko H.J.","year":"2017","unstructured":"Nnko H.J.; Ngonyoka A.; Salekwa L.; Estes A.B.; Hudson P.J.; Gwakisa P.S.; Cattadori I.M.; Seasonal variation of tsetse fly species abundance and prevalence of trypanosomes in the Maasai Steppe, Tanzania. J Vector Ecol  2017,42(1),24-33","journal-title":"J Vector Ecol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-444-53490-3.00011-X","volume":"Vol. 114","author":"Lejon V.","year":"2013","unstructured":"Lejon V.; Bentivoglio M.; Franco J.R.;  Human African Trypanosomiasis Handbook of Clinical Neurology  2013,Vol. 114,169-181","journal-title":"Human African Trypanosomiasis Handbook of Clinical Neurology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e0010885","DOI":"10.1371\/journal.pntd.0010885","volume":"16","author":"Franco J.R.","year":"2022","unstructured":"Franco J.R.; Cecchi G.; Priotto G.; Paone M.; Kadima Ebeja A.; Simarro P.P.; Diarra A.; Sankara D.; Zhao W.; Dagne D.A.; Human African trypanosomiasis cases diagnosed in non-endemic countries (2011\u20132020). PLoS Negl Trop Dis  2022,16(11),e0010885","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=26","unstructured":"Neglected tropical diseases: Sleeping sickness (human African trypanosomiasis).   Available from:  https:\/\/www.who. int\/news-room\/questions-and-answers\/item\/neglected-topical-diseases-sleeping-sickness-(human-african-trypano-somiasis) (accessed on 12-7-2024)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fimmu.2019.00039","volume":"10","author":"Kennedy P.G.E.","year":"2019","unstructured":"Kennedy P.G.E.; Rodgers J.; Clinical and neuropathogenetic aspects of human African trypanosomiasis. Front Immunol  2019,10,39","journal-title":"Front Immunol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4614-8100-3_9","author":"Buguet A.","year":"2014","unstructured":"Buguet A.; Mpanzou G.; Bentivoglio M.; Human African trypanosomiasis: A highly neglected neurological disease. Neglected Tropical Diseases and Conditions of the Nervous System  2014,165-181","journal-title":"Neglected Tropical Diseases and Conditions of the Nervous System"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e1211","DOI":"10.1371\/journal.pntd.0001211","volume":"5","author":"Anderson N.E.","year":"2011","unstructured":"Anderson N.E.; Mubanga J.; Fevre E.M.; Picozzi K.; Eisler M.C.; Thomas R.; Welburn S.C.; Characterisation of the wildlife reservoir community for human and animal trypanosomiasis in the Luangwa Valley, Zambia. PLoS Negl Trop Dis  2011,5(6),e1211","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=30","first-page":"727","volume":"86","author":"Gupta M.P.","year":"2009","unstructured":"Gupta M.P.; Kumar H.; Singla L.D.; Trypanosomosis concurrent to tuberculosis in Black Bucks. Indian Vet J  2009,86,727-728","journal-title":"Indian Vet J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.pt.2016.05.003","volume":"32","author":"Auty H.","year":"2016","unstructured":"Auty H.; Morrison L.J.; Torr S.J.; Lord J.; Transmission dynamics of rhodesian sleeping sickness at the interface of wildlife and livestock areas. Trends Parasitol  2016,32(8),608-621","journal-title":"Trends Parasitol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/ismej.2014.236","volume":"9","author":"Geiger A.","year":"2015","unstructured":"Geiger A.; Ponton F.; Simo G.; Adult blood-feeding tsetse flies, trypanosomes, microbiota and the fluctuating environment in sub-Saharan Africa. ISME J  2015,9(7),1496-1507","journal-title":"ISME J"},{"key":"ref=33","unstructured":"African trypanosomiasis \u2014 Level 3 cause, Institute for Health Metrics and Evaluation.  Available from:  https:\/\/www.healthdata.org\/results\/gbd_summaries\/2019\/african-trypanosomiasis-level-3-cause(accessed on 12-7-2024)"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.4155\/fmc.13.129","volume":"5","author":"Miller B.R.","year":"2013","unstructured":"Miller B.R.; Roitberg A.E.; Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis). Future Med Chem  2013,5(15),1889-1900","journal-title":"Future Med Chem"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/RIP.S57144","volume":"7","author":"Gascon J.","year":"2015","unstructured":"Gascon J.; Pinazo M.J.; Chagas disease: From latin america to the world. RIP  2015,7,7-14","journal-title":"RIP"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/401864","volume":"2014","author":"Cevallos A.M.","year":"2014","unstructured":"Cevallos A.M.; Hern\u00e1ndez R.; Chagas\u2019 disease: pregnancy and congenital transmission. BioMed Res Int  2014,2014,1-10","journal-title":"BioMed Res Int"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-9292-3-2","volume":"3","author":"Vaidian A.K.","year":"2004","unstructured":"Vaidian A.K.; Weiss L.M.; Tanowitz H.B.; Chagas\u2019 disease and AIDS. Kinetoplastid Biol Dis  2004,3(1),2","journal-title":"Kinetoplastid Biol Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.actatropica.2015.06.003","volume":"150","author":"Keating J.","year":"2015","unstructured":"Keating J.; Yukich J.O.; Sutherland C.S.; Woods G.; Tediosi F.; Human African trypanosomiasis prevention, treatment and control costs: A systematic review. Acta Trop  2015,150,4-13","journal-title":"Acta Trop"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1017\/S0031182006001259","volume":"134","author":"G\u00fcrtler R.E.","year":"2007","unstructured":"G\u00fcrtler R.E.; Cecere M.C.; Lauricella M.A.; Cardinal M.V.; Kitron U.; Cohen J.E.; Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina. Parasitology  2007,134(1),69-82","journal-title":"Parasitology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-3-030-53230-7_5","volume":"Vol. 13","author":"G\u00fcrtler R.E.","year":"2021","unstructured":"G\u00fcrtler R.E.; Cardinal M.V.; Dogs and Their Role in the Eco-Epidemiology of Chagas Disease. Dog Parasites Endangering Human Health  2021,Vol. 13,73-106","journal-title":"Dog Parasites Endangering Human Health"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1590\/0074-0276140236","volume":"109","author":"Coura J.R.","year":"2014","unstructured":"Coura J.R.; Vi\u00f1as P.A.; Junqueira A.C.V.; Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries. Mem Inst Oswaldo Cruz  2014,109(7),856-862","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=42","first-page":"276","volume":"45","author":"Moncayo A.","year":"1992","unstructured":"Moncayo A.; Chagas disease: epidemiology and prospects for interruption of transmission in the Americas. World Health Stat Q  1992,45(2-3),276-279","journal-title":"World Health Stat Q"},{"key":"ref=43","unstructured":"Clinical Considerations for Congenital Chagas Disease.  Available from:  https:\/\/www.cdc.gov\/parasites\/chagas\/gen_info\/detailed.html (accessed on 12-7-2024)"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"112020","DOI":"10.1016\/j.biopha.2021.112020","volume":"142","author":"Garc\u00eda-Huertas P.","year":"2021","unstructured":"Garc\u00eda-Huertas P.; Cardona-Castro N.; Advances in the treatment of Chagas disease: Promising new drugs, plants and targets. Biomed Pharmacother  2021,142,112020","journal-title":"Biomed Pharmacother"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/tropicalmed5010014","volume":"5","author":"De Koning P.H.","year":"2020","unstructured":"De Koning P.H.; The drugs of sleeping sickness: Their mechanisms of action and resistance, and a brief history. TropicalMed  2020,5(1),14","journal-title":"TropicalMed"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.biochi.2008.02.017","volume":"90","author":"Wilson W.D.","year":"2008","unstructured":"Wilson W.D.; Tanious F.A.; Mathis A.; Tevis D.; Hall J.E.; Boykin D.W.; Antiparasitic compounds that target DNA. Biochimie  2008,90(7),999-1014","journal-title":"Biochimie"},{"key":"ref=47","first-page":"125","volume":"Vol. 63","author":"Barrett M.P.","year":"2006","unstructured":"Barrett M.P.; Gilbert I.H.;  Targeting of toxic compounds to the trypanosome\u2019s interior Advances in Parasitology  2006,Vol. 63,125-183","journal-title":"Targeting of toxic compounds to the trypanosome\u2019s interior Advances in Parasitology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2217\/fmb.11.44","volume":"6","author":"Brun R.","year":"2011","unstructured":"Brun R.; Don R.; Jacobs R.T.; Wang M.Z.; Barrett M.P.; Development of novel drugs for human African trypanosomiasis. Future Microbiol  2011,6(6),677-691","journal-title":"Future Microbiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1124\/jpet.108.149872","volume":"329","author":"Sanderson L.","year":"2009","unstructured":"Sanderson L.; Dogruel M.; Rodgers J.; De Koning H.P.; Thomas S.A.; Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycopro-tein, and multidrug resistance-associated protein. J Pharmacol Exp Ther  2009,329(3),967-977","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0001-706X(01)00177-2","volume":"80","author":"de Koning H.P.","year":"2001","unstructured":"de Koning H.P.; Jarvis S.M.; Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter. Acta Trop  2001,80(3),245-250","journal-title":"Acta Trop"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1128\/AAC.48.5.1515-1519.2004","volume":"48","author":"de Koning H.P.","year":"2004","unstructured":"de Koning H.P.; Anderson L.F.; Stewart M.; Burchmore R.J.S.; Wallace L.J.M.; Barrett M.P.; The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes. Antimicrob Agents Chemother  2004,48(5),1515-1519","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1128\/EC.2.5.1003-1008.2003","volume":"2","author":"Matovu E.","year":"2003","unstructured":"Matovu E.; Stewart M.L.; Geiser F.; Brun R.; M\u00e4ser P.; Wallace L.J.M.; Burchmore R.J.; Enyaru J.C.K.; Barrett M.P.; Kaminsky R.; Seebeck T.; de Koning H.P.; Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Eukaryot Cell  2003,2(5),1003-1008","journal-title":"Eukaryot Cell"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10771","volume":"482","author":"Alsford S.","year":"2012","unstructured":"Alsford S.; Eckert S.; Baker N.; Glover L.; Sanchez-Flores A.; Leung K.F.; Turner D.J.; Field M.C.; Berriman M.; Horn D.; High-throughput decoding of antitrypanosomal drug efficacy and resistance. Nature  2012,482(7384),232-236","journal-title":"Nature"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2165\/00003495-198733030-00002","volume":"33","author":"Goa K.L.","year":"1987","unstructured":"Goa K.L.; Campoli-Richards D.M.; Pentamidine Isethionate. Drugs  1987,33(3),242-258","journal-title":"Drugs"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","volume":"19","author":"Fairlamb A.H.","year":"2003","unstructured":"Fairlamb A.H.; Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol  2003,19(11),488-494","journal-title":"Trends Parasitol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"e01168","DOI":"10.1128\/AAC.01168-19","volume":"64","author":"Wiedemar N.","year":"2020","unstructured":"Wiedemar N.; Hauser D.A.; M\u00e4ser P.; 100 Years of Suramin. Antimicrob Agents Chemother  2020,64(3),e01168-e19","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=57","first-page":"1","volume":"Vol. 33","author":"P\u00e9pin J.","year":"1994","unstructured":"P\u00e9pin J.; Milord F.;  The Treatment of Human African Trypanosomiasis Advances in Parasitology  1994,Vol. 33,1-47","journal-title":"The Treatment of Human African Trypanosomiasis Advances in Parasitology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/B978-0-12-394295-1.00026-3","author":"Lin Y.","year":"2014","unstructured":"Lin Y.; Gerson S.L.; Clinical Trials Using LV-P140K-MGMT for Gliomas. Gene Therapy of Cancer  2014,379-391","journal-title":"Gene Therapy of Cancer"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0163-7258(80)90035-2","volume":"11","author":"Apted F.I.C.","year":"1980","unstructured":"Apted F.I.C.; Present status of chemotherapy and chemoprohylaxis of human trypanosomiasis in the Eastern Hemisphere. Pharmacol Ther  1980,11(2),391-413","journal-title":"Pharmacol Ther"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.6775372","volume":"210","author":"Bacchi C.J.","year":"1980","unstructured":"Bacchi C.J.; Nathan H.C.; Hutner S.H.; McCann P.P.; Sjoerdsma A.; Polyamine metabolism: a potential therapeutic target in trypanosomes. Science  1980,210(4467),332-334","journal-title":"Science"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/diseases10040090","volume":"10","author":"Bernhard S.","year":"2022","unstructured":"Bernhard S.; Kaiser M.; Burri C.; M\u00e4ser P.; Fexinidazole for human african trypanosomiasis, the fruit of a successful public-private partnership. Diseases  2022,10(4),90","journal-title":"Diseases"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e2910","DOI":"10.1371\/journal.pntd.0002910","volume":"8","author":"Ebikeme C.","year":"2014","unstructured":"Ebikeme C.; The death and life of the resurrection drug. PLoS Negl Trop Dis  2014,8(7),e2910","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1128\/AAC.34.6.1183","volume":"34","author":"Bacchi C.J.","year":"1990","unstructured":"Bacchi C.J.; Nathan H.C.; Livingston T.; Valladares G.; Saric M.; Sayer P.D.; Njogu A.R.; Clarkson A.B.; Jr. Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense. Antimicrob Agents Chemother  1990,34(6),1183-1188","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=64","first-page":"190","volume":"46","author":"Iten M.","year":"1995","unstructured":"Iten M.; Matovu E.; Brun R.; Kaminsky R.; Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO). Trop Med Parasitol  1995,46(3),190-194","journal-title":"Trop Med Parasitol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e1001204","DOI":"10.1371\/journal.ppat.1001204","volume":"6","author":"Vincent I.M.","year":"2010","unstructured":"Vincent I.M.; Creek D.; Watson D.G.; Kamleh M.A.; Woods D.J.; Wong P.E.; Burchmore R.J.S.; Barrett M.P.; A molecular mechanism for eflornithine resistance in African trypanosomes. PLoS Pathog  2010,6(11),e1001204","journal-title":"PLoS Pathog"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1007\/s00436-002-0766-5","volume":"90","author":"Burri C.","year":"2003","unstructured":"Burri C.; Brun R.; Eflornithine for the treatment of human African trypanosomiasis. Parasitol Res  2003,90(Suppl. 1),S49-S52","journal-title":"Parasitol Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","volume":"152","author":"Barrett M.P.","year":"2007","unstructured":"Barrett M.P.; Boykin D.W.; Brun R.; Tidwell R.R.; Human African trypanosomiasis: Pharmacological re-engagement with a neglected disease. Br J Pharmacol  2007,152(8),1155-1171","journal-title":"Br J Pharmacol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e0006980","DOI":"10.1371\/journal.pntd.0006980","volume":"12","author":"Thomas J.A.","year":"2018","unstructured":"Thomas J.A.; Baker N.; Hutchinson S.; Dominicus C.; Trenaman A.; Glover L.; Alsford S.; Horn D.; Insights into antitrypanosomal drug mode-of-action from cytology-based profiling. PLoS Negl Trop Dis  2018,12(11),e0006980","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","volume":"34","author":"Fairlamb A.H.","year":"2018","unstructured":"Fairlamb A.H.; Horn D.; Melarsoprol Resistance in African Trypanosomiasis. Trends Parasitol  2018,34(6),481-492","journal-title":"Trends Parasitol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00436-002-0799-9","volume":"90","author":"Nok A.J.","year":"2003","unstructured":"Nok A.J.; Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res  2003,90(1),71-79","journal-title":"Parasitol Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1087003","DOI":"10.3389\/fitd.2023.1087003","volume":"4","author":"Papagni R.","year":"2023","unstructured":"Papagni R.; Novara R.; Minardi M.L.; Frallonardo L.; Panico G.G.; Pallara E.; Cotugno S.; Ascoli Bartoli T.; Guido G.; De Vita E.; Ricciardi A.; Totaro V.; Camporeale M.; Segala F.V.; Bavaro D.F.; Patti G.; Brindicci G.; Pellegrino C.; Mariani M.F.; Putoto G.; Sarmati L.; Castellani C.; Saracino A.; Di Gennaro F.; Nicastri E.; Human African trypanosomiasis (sleeping sickness): Current knowledge and future challenges. Front Tropical Dis  2023,4,1087003","journal-title":"Front Tropical Dis"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/jac\/dkt442","volume":"69","author":"Munday J.C.","year":"2014","unstructured":"Munday J.C.; Eze A.A.; Baker N.; Glover L.; Clucas C.; Aguinaga Andr\u00e9s D.; Natto M.J.; Teka I.A.; McDonald J.; Lee R.S.; Graf F.E.; Ludin P.; Burchmore R.J.S.; Turner C.M.R.; Tait A.; MacLeod A.; M\u00e4ser P.; Barrett M.P.; Horn D.; De Koning H.P.; Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs. J Antimicrob Chemother  2014,69(3),651-663","journal-title":"J Antimicrob Chemother"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1086\/429929","volume":"191","author":"Schmid C.","year":"2005","unstructured":"Schmid C.; Richer M.; Bilenge C.M.M.; Josenando T.; Chappuis F.; Manthelot C.R.; Nangouma A.; Doua F.; Asumu P.N.; Simarro P.P.; Burri C.; Impamel I.I.; Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). J Infect Dis  2005,191(11),1922-1931","journal-title":"J Infect Dis"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1073\/pnas.0711014105","volume":"105","author":"Wilkinson S.R.","year":"2008","unstructured":"Wilkinson S.R.; Taylor M.C.; Horn D.; Kelly J.M.; Cheeseman I.; A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc Natl Acad Sci USA  2008,105(13),5022-5027","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1016\/S0021-9258(18)50687-6","volume":"254","author":"Peterson F.J.","year":"1979","unstructured":"Peterson F.J.; Mason R.P.; Hovsepian J.; Holtzman J.L.; Oxygen-sensitive and -insensitive nitroreduction by Escherichia coli and rat hepatic microsomes. J Biol Chem  1979,254(10),4009-4014","journal-title":"J Biol Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","volume":"286","author":"Hall B.S.","year":"2011","unstructured":"Hall B.S.; Bot C.; Wilkinson S.R.; Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites. J Biol Chem  2011,286(15),13088-13095","journal-title":"J Biol Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jac\/dkz473","volume":"75","author":"Jackson Y.","year":"2020","unstructured":"Jackson Y.; Wyssa B.; Chappuis F.; Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas\u2019 disease. J Antimicrob Chemother  2020,75(3),690-696","journal-title":"J Antimicrob Chemother"},{"key":"ref=78","author":"Altcheh D.J.","year":"2023","unstructured":"Altcheh D.J.; Nifurtimox versus benznidazole effectiveness, and tolerance for chagas disease treatment, retrospective cohort. Patent NCT04274101,  2023","journal-title":"Patent NCT04274101,"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/0972-9062.289397","volume":"56","author":"Munoz-Calderon A.","year":"2019","unstructured":"Munoz-Calderon A.; D\u00edaz-Bello Z.; Ram\u00edrez J.; Noya O.; de Noya B.; Nifurtimox response of Trypanosoma cruzi isolates from an outbreak of Chagas disease in Caracas, Venezuela. J Vector Borne Dis  2019,56(3),237-243","journal-title":"J Vector Borne Dis"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","volume":"374","author":"Priotto G.","year":"2009","unstructured":"Priotto G.; Kasparian S.; Mutombo W.; Ngouama D.; Ghorashian S.; Arnold U.; Ghabri S.; Baudin E.; Buard V.; Kazadi-Kyanza S.; Ilunga M.; Mutangala W.; Pohlig G.; Schmid C.; Karunakara U.; Torreele E.; Kande V.; Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet  2009,374(9683),56-64","journal-title":"Lancet"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0166-6851(01)00430-3","volume":"119","author":"Marques Porto R.","year":"2002","unstructured":"Marques Porto R.; Amino R.; Elias M.C.Q.; Faria M.; Schenkman S.; Histone H1 is phosphorylated in non-replicating and infective forms of Trypanosoma cruzi. Mol Biochem Parasitol  2002,119(2),265-271","journal-title":"Mol Biochem Parasitol"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.17352\/2455-5363.000033","volume":"6","author":"Omowumi T.","year":"2020","unstructured":"Omowumi T.; Trypanosomiasis: Recent advances in strategies for control. Glob J Infect Dis Clin Res  2020,6,37-41","journal-title":"Glob J Infect Dis Clin Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.actatropica.2006.09.003","volume":"100","author":"Likeufack A.C.L.","year":"2006","unstructured":"Likeufack A.C.L.; Brun R.; Fomena A.; Truc P.; Comparison of the in vitro drug sensitivity of Trypanosoma brucei gambiense strains from West and central Africa isolated in the periods 1960-1995 and 1999-2004. Acta Trop  2006,100(1-2),11-16","journal-title":"Acta Trop"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.1074\/jbc.RA120.012355","volume":"295","author":"Zoltner M.","year":"2020","unstructured":"Zoltner M.; Campagnaro G.D.; Taleva G.; Burrell A.; Cerone M.; Leung K.F.; Achcar F.; Horn D.; Vaughan S.; Gadelha C.; Z\u00edkov\u00e1 A.; Barrett M.P.; de Koning H.P.; Field M.C.; Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes. J Biol Chem  2020,295(24),8331-8347","journal-title":"J Biol Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1002\/j.1460-2075.1996.tb00934.x","volume":"15","author":"Coulombe R.","year":"1996","unstructured":"Coulombe R.; Grochulski P.; Sivaraman J.; M\u00e9nard R.; Mort J.S.; Cygler M.; Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J  1996,15(20),5492-5503","journal-title":"EMBO J"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1242\/jcs.01677","volume":"118","author":"Santos C.C.","year":"2005","unstructured":"Santos C.C.; Sant\u2019anna C.; Terres A.; Cunha-e-Silva N.L.; Scharfstein J.; de A Lima, A.P. Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells. J Cell Sci  2005,118(Pt 5),901-915","journal-title":"J Cell Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nrg1111","volume":"4","author":"Puente X.S.","year":"2003","unstructured":"Puente X.S.; S\u00e1nchez L.M.; Overall C.M.; L\u00f3pez-Ot\u00edn C.; Human and mouse proteases: a comparative genomic approach. Nat Rev Genet  2003,4(7),544-558","journal-title":"Nat Rev Genet"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1021\/acscatal.7b01505","volume":"7","author":"Els\u00e4sser B.","year":"2017","unstructured":"Els\u00e4sser B.; Zauner F.B.; Messner J.; Soh W.T.; Dall E.; Brandstetter H.; Distinct roles of catalytic cysteine and histidine in the protease and ligase mechanisms of human legumain as revealed by DFT-based QM\/MM simulations. ACS Catal  2017,7(9),5585-5593","journal-title":"ACS Catal"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","volume":"1824","author":"Turk V.","year":"2012","unstructured":"Turk V.; Stoka V.; Vasiljeva O.; Renko M.; Sun T.; Turk B.; Turk D.; Cysteine cathepsins: From structure, function and regulation to new frontiers. Biochim Biophys Acta Proteins Proteomics  2012,1824(1),68-88","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/345195","volume":"2012","author":"Pandey K.C.","year":"2012","unstructured":"Pandey K.C.; Dixit R.; Structure-function of falcipains: malarial cysteine proteases. J Trop Med  2012,2012,1-11","journal-title":"J Trop Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0166-6851(01)00438-8","volume":"120","author":"Sajid M.","year":"2002","unstructured":"Sajid M.; McKerrow J.H.; Cysteine proteases of parasitic organisms. Mol Biochem Parasitol  2002,120(1),1-21","journal-title":"Mol Biochem Parasitol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ijpara.2012.03.009","volume":"42","author":"Steverding D.","year":"2012","unstructured":"Steverding D.; Sexton D.W.; Wang X.; Gehrke S.S.; Wagner G.K.; Caffrey C.R.; Trypanosoma brucei: Chemical evidence that cathepsin L is essential for survival and a relevant drug target. Int J Parasitol  2012,42(5),481-488","journal-title":"Int J Parasitol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"6722","DOI":"10.1021\/acsomega.0c05645","volume":"6","author":"Rosas-Jimenez J.G.","year":"2021","unstructured":"Rosas-Jimenez J.G.; Garcia-Revilla M.A.; Madariaga-Mazon A.; Martinez-Mayorga K.; Predictive global models of cruzain inhibitors with large chemical coverage. ACS Omega  2021,6(10),6722-6735","journal-title":"ACS Omega"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"e12980","DOI":"10.1111\/cmi.12980","volume":"21","author":"Koeller C.M.","year":"2019","unstructured":"Koeller C.M.; Bangs J.D.; Processing and targeting of cathepsin L (TbCatL) to the lysosome in Trypanosoma brucei. Cell Microbiol  2019,21(4),e12980","journal-title":"Cell Microbiol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1242\/jcs.115.16.3253","volume":"115","author":"Alexander D.L.","year":"2002","unstructured":"Alexander D.L.; Schwartz K.J.; Balber A.E.; Bangs J.D.; Developmentally regulated trafficking of the lysosomal membrane protein p67 in Trypanosoma brucei. J Cell Sci  2002,115(16),3253-3263","journal-title":"J Cell Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1091\/mbc.E18-06-0380","volume":"29","author":"Tiengwe C.","year":"2018","unstructured":"Tiengwe C.; Koeller C.M.; Bangs J.D.; Endoplasmic reticulum\u2013associated degradation and disposal of misfolded GPI-anchored proteins in Trypanosoma brucei. Mol Biol Cell  2018,29(20),2397-2409","journal-title":"Mol Biol Cell"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/123702","volume":"2011","author":"Coley A.F.","year":"2011","unstructured":"Coley A.F.; Dodson H.C.; Morris M.T.; Morris J.C.; Glycolysis in the african trypanosome: targeting enzymes and their subcellular compartments for therapeutic development. Mol Biol Int  2011,2011,1-10","journal-title":"Mol Biol Int"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"111246","DOI":"10.1016\/j.molbiopara.2019.111246","volume":"235","author":"Steverding D.","year":"2020","unstructured":"Steverding D.; Rushworth S.A.; Florea B.I.; Overkleeft H.S.; Trypanosoma brucei: Inhibition of cathepsin L is sufficient to kill bloodstream forms. Mol Biochem Parasitol  2020,235,111246","journal-title":"Mol Biochem Parasitol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/ijms24010656","volume":"24","author":"Costa T.F.R.","year":"2022","unstructured":"Costa T.F.R.; Goundry A.; Morrot A.; Grab D.J.; Mottram J.C.; Lima A.P.C.A.; Trypanosoma brucei rhodesi-ense inhibitor of cysteine peptidase (icp) is required for virulence in mice and to attenuate the inflammatory response. Int J Mol Sci  2022,24(1),656","journal-title":"Int J Mol Sci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"48426","DOI":"10.1074\/jbc.M402470200","volume":"279","author":"Mackey Z.B.","year":"2004","unstructured":"Mackey Z.B.; O\u2019Brien T.C.; Greenbaum D.C.; Blank R.B.; McKerrow J.H.; A cathepsin B-like protease is required for host protein degradation in Trypanosoma brucei. J Biol Chem  2004,279(46),48426-48433","journal-title":"J Biol Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1371\/journal.pntd.0000298","volume":"2","author":"Abdulla M.H.","year":"2008","unstructured":"Abdulla M.H.; O\u2019Brien T.; Mackey Z.B.; Sajid M.; Grab D.J.; McKerrow J.H.; RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model. PLoS Negl Trop Dis  2008,2(9),e298","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1021\/jm070760l","volume":"51","author":"Mallari J.P.","year":"2008","unstructured":"Mallari J.P.; Shelat A.A.; Obrien T.; Caffrey C.R.; Kosinski A.; Connelly M.; Harbut M.; Greenbaum D.; McKerrow J.H.; Guy R.K.; Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB. J Med Chem  2008,51(3),545-552","journal-title":"J Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.2174\/1389557515666160509125243","volume":"16","author":"Ettari R.","year":"2016","unstructured":"Ettari R.; Previti S.; Tamborini L.; Cullia G.; Grasso S.; Zappal\u00e0 M.; The inhibition of cysteine proteases rhodesain and TbCatB: A valuable approach to treat human african trypanosomiasis. Mini Rev Med Chem  2016,16(17),1374-1391","journal-title":"Mini Rev Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"e701","DOI":"10.1371\/journal.pntd.0000701","volume":"4","author":"Kerr I.D.","year":"2010","unstructured":"Kerr I.D.; Wu P.; Marion-Tsukamaki R.; Mackey Z.B.; Brinen L.S.; Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei. PLoS Negl Trop Dis  2010,4(6),e701","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"10097","DOI":"10.3390\/ijms241210097","volume":"24","author":"Ettari R.","year":"2023","unstructured":"Ettari R.; Cysteine proteases as validated targets for the treatment of neglected and poverty-related parasitic diseases. Int J Mol Sci  2023,24(12),10097","journal-title":"Int J Mol Sci"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1389450003349290","volume":"1","author":"Caffrey C.","year":"2000","unstructured":"Caffrey C.; Scory S.; Steverding D.; Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy. Curr Drug Targets  2000,1(2),155-162","journal-title":"Curr Drug Targets"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2174\/1381612013397528","volume":"7","author":"Cazzulo J.","year":"2001","unstructured":"Cazzulo J.; Stoka V.; Turk V.; The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease. Curr Pharm Des  2001,7(12),1143-1156","journal-title":"Curr Pharm Des"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/15548627.2020.1720428","volume":"17","author":"Losinno A.D.","year":"2021","unstructured":"Losinno A.D.; Mart\u00ednez S.J.; Labriola C.A.; Carrillo C.; Romano P.S.; Induction of autophagy increases the proteolytic activity of reservosomes during Trypanosoma cruzi metacyclogenesis. Autophagy  2021,17(2),439-456","journal-title":"Autophagy"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"18231","DOI":"10.1038\/s41598-021-97490-2","volume":"11","author":"Santos V.C.","year":"2021","unstructured":"Santos V.C.; Oliveira A.E.R.; Campos A.C.B.; Reis-Cunha J.L.; Bartholomeu D.C.; Teixeira S.M.R.; Lima A.P.C.A.; Ferreira R.S.; The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites. Sci Rep  2021,11(1),18231","journal-title":"Sci Rep"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1590\/S0074-02761997000600016","volume":"92","author":"Zingales B.","year":"1997","unstructured":"Zingales B.; Pereira M.E.S.; Almeida K.A.; Umezawa E.S.; Nehme N.S.; Oliveira R.P.; Macedo A.; Souto R.P.; Biological parameters and molecular markers of clone CL Brener--the reference organism of the Trypanosoma cruzi genome project. Mem Inst Oswaldo Cruz  1997,92(6),811-814","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"116577","DOI":"10.1016\/j.bmc.2021.116577","volume":"58","author":"Beltran-Hortelano I.","year":"2022","unstructured":"Beltran-Hortelano I.; Alcolea V.; Font M.; P\u00e9rez-Silanes S.; Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease. Bioorg Med Chem  2022,58,116577","journal-title":"Bioorg Med Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.1016\/S0021-9258(18)42533-1","volume":"267","author":"Eakin A.E.","year":"1992","unstructured":"Eakin A.E.; Mills A.A.; Harth G.; McKerrow J.H.; Craik C.S.; The sequence, organization, and expression of the major cysteine protease (cruzain) from Trypanosoma cruzi. J Biol Chem  1992,267(11),7411-7420","journal-title":"J Biol Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1107\/S2053230X19006320","volume":"75","author":"Barbosa da Silva E.","year":"2019","unstructured":"Barbosa da Silva E.; Dall E.; Briza P.; Brandstetter H.; Ferreira R.S.; Cruzain structures: apocruzain and cruzain bound to S -methyl thiomethanesulfonate and implications for drug design. Acta Crystallogr F Struct Biol Commun  2019,75(6),419-427","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2174\/0929867330666230619160509","volume":"31","author":"Saha A.","year":"2023","unstructured":"Saha A.; Targeting cysteine proteases and their inhibitors to combat trypanosomiasis. Curr Med Chem  2023,31(16),2135-2169","journal-title":"Curr Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1006\/jmbi.1994.0137","volume":"247","author":"McGrath M.E.","year":"1995","unstructured":"McGrath M.E.; Eakin A.E.; Engel J.C.; McKerrow J.H.; Craik C.S.; Fletterick R.J.; The crystal structure of cruzain: a therapeutic target for Chagas\u2019 disease. J Mol Biol  1995,247(2),251-259","journal-title":"J Mol Biol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"e0222055","DOI":"10.1371\/journal.pone.0222055","volume":"14","author":"Sartori G.R.","year":"2019","unstructured":"Sartori G.R.; Leit\u00e3o A.; Montanari C.A.; Laughton C.A.; Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors. PLoS One  2019,14(12),e0222055","journal-title":"PLoS One"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.1016\/j.csbj.2022.11.040","volume":"20","author":"Petushkova A.I.","year":"2022","unstructured":"Petushkova A.I.; Savvateeva L.V.; Zamyatnin A.A.; Structure determinants defining the specificity of papain-like cysteine proteases. Comput Struct Biotechnol J  2022,20,6552-6569","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.drudis.2015.02.004","volume":"20","author":"Martinez-Mayorga K.","year":"2015","unstructured":"Martinez-Mayorga K.; Byler K.G.; Ramirez-Hernandez A.I.; Terrazas-Alvares D.E.; Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits. Drug Discov Today  2015,20(7),890-898","journal-title":"Drug Discov Today"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41579-022-00777-y","volume":"21","author":"De Rycker M.","year":"2023","unstructured":"De Rycker M.; Wyllie S.; Horn D.; Read K.D.; Gilbert I.H.; Anti-trypanosomatid drug discovery: progress and challenges. Nat Rev Microbiol  2023,21(1),35-50","journal-title":"Nat Rev Microbiol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"16092","DOI":"10.1038\/nmicrobiol.2016.92","volume":"1","author":"Fairlamb A.H.","year":"2016","unstructured":"Fairlamb A.H.; Gow N.A.R.; Matthews K.R.; Waters A.P.; Drug resistance in eukaryotic microorganisms. Nat Microbiol  2016,1(7),16092","journal-title":"Nat Microbiol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/17460441.2020.1704729","volume":"15","author":"Talevi A.","year":"2020","unstructured":"Talevi A.; Bellera C.L.; Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics. Expert Opin Drug Discov  2020,15(4),397-401","journal-title":"Expert Opin Drug Discov"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2174\/1568026623666221201150933","volume":"23","author":"Saha A.","year":"2023","unstructured":"Saha A.; Samadder A.; Nandi S.; Stem cell therapy in combination with naturopathy: Current progressive management of diabetes and associated complications. Curr Top Med Chem  2023,23(8),649-689","journal-title":"Curr Top Med Chem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.52756\/bhietm.2022.e01.001","author":"Saha A.","year":"2022","unstructured":"Saha A.; Moitra S.; Sanyal T.; Anticancer and antidiabetic potential of phytochemicals derived from catharanthus roseus: A key emphasis to vinca alkaloids.  2022,1-19"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"46","DOI":"10.52756\/bhietm.2022.e01.004","author":"Raha S.","year":"2022","unstructured":"Raha S.; Mukherjee P.; Saha A.; Sanyal T.; Aquatic macrophytes: An untold and valuable panoramic resource of ethnomedicine. The Basic Handbook of Indian Ethnobotany and Traditional Medicine  2022,46-61","journal-title":"The Basic Handbook of Indian Ethnobotany and Traditional Medicine"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1080\/14786419.2021.1978993","volume":"36","author":"Di Chio C.","year":"2022","unstructured":"Di Chio C.; Previti S.; De Luca F.; Allegra A.; Zappal\u00e0 M.; Ettari R.; Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense. Nat Prod Res  2022,36(16),4282-4286","journal-title":"Nat Prod Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-8741(96)01463-8","volume":"55","author":"Freiburghaus F.","year":"1996","unstructured":"Freiburghaus F.; Kaminsky R.; Nkunya M.H.H.; Brun R.; Evaluation of African medicinal plants for their in vitro trypanocidal activity. J Ethnopharmacol  1996,55(1),1-11","journal-title":"J Ethnopharmacol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1021\/jm301424d","volume":"56","author":"Ettari R.","year":"2013","unstructured":"Ettari R.; Tamborini L.; Angelo I.C.; Micale N.; Pinto A.; De Micheli C.; Conti P.; Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis. J Med Chem  2013,56(14),5637-5658","journal-title":"J Med Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1016\/j.bmcl.2012.07.104","volume":"22","author":"Lavrado J.","year":"2012","unstructured":"Lavrado J.; Mackey Z.; Hansell E.; McKerrow J.H.; Paulo A.; Moreira R.; Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives. Bioorg Med Chem Lett  2012,22(19),6256-6260","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1016\/j.bmc.2010.02.034","volume":"18","author":"Watts K.R.","year":"2010","unstructured":"Watts K.R.; Ratnam J.; Ang K.H.; Tenney K.; Compton J.E.; McKerrow J.; Crews P.; Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi. Bioorg Med Chem  2010,18(7),2566-2574","journal-title":"Bioorg Med Chem"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1080\/07391102.2022.2092550","volume":"41","author":"Elrufaie H.A.","year":"2023","unstructured":"Elrufaie H.A.; Mohamed L.M.; Hamd A.Y.; Bala N.A.; Elbadawi F.A.; Ghaboosh H.; Alzain A.A.; Discovery of novel natural products as rhodesain inhibitors for human African trypanosomiasis using in silico techniques. J Biomol Struct Dyn  2023,41(12),5672-5684","journal-title":"J Biomol Struct Dyn"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1080\/14786419.2018.1483927","volume":"33","author":"Ettari R.","year":"2019","unstructured":"Ettari R.; Previti S.; Maiorana S.; Allegra A.; Schirmeister T.; Grasso S.; Zappal\u00e0 M.; Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense. Nat Prod Res  2019,33(24),3577-3581","journal-title":"Nat Prod Res"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.3390\/md12052614","volume":"12","author":"Oli S.","year":"2014","unstructured":"Oli S.; Abdelmohsen U.; Hentschel U.; Schirmeister T.; Identification of plakortide E from the Caribbean sponge Plakortis halichondroides as a trypanocidal protease inhibitor using bioactivity-guided fractionation. Mar Drugs  2014,12(5),2614-2622","journal-title":"Mar Drugs"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1007\/s00436-016-5227-7","volume":"115","author":"Steverding D.","year":"2016","unstructured":"Steverding D.; da N\u00f3brega F.R.; Rushworth S.A.; de Sousa D.P.; Trypanocidal and cysteine protease inhibitory activity of isopentyl caffeate is not linked in Trypanosoma brucei. Parasitol Res  2016,115(11),4397-4403","journal-title":"Parasitol Res"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1021\/acs.jnatprod.9b00885","volume":"83","author":"Kossack R.","year":"2020","unstructured":"Kossack R.; Breinlinger S.; Nguyen T.; Moschny J.; Straetener J.; Berscheid A.; Br\u00f6tz-Oesterhelt H.; Enke H.; Schirmeister T.; Niedermeyer T.H.J.; Nostotrebin 6 related cyclopentenediones and \u03b4-lactones with broad activity spectrum isolated from the cultivation medium of the cyanobacterium Nostoc sp. CBT1153. J Nat Prod  2020,83(2),392-400","journal-title":"J Nat Prod"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1016\/j.bmcl.2010.07.062","volume":"20","author":"Waag T.","year":"2010","unstructured":"Waag T.; Gelhaus C.; Rath J.; Stich A.; Leippe M.; Schirmeister T.; Allicin and derivates are cysteine protease inhibitors with antiparasitic activity. Bioorg Med Chem Lett  2010,20(18),5541-5543","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cbpa.2006.03.004","volume":"146","author":"Maya J.D.","year":"2007","unstructured":"Maya J.D.; Cassels B.K.; Iturriaga-V\u00e1squez P.; Ferreira J.; Fa\u00fandez M.; Galanti N.; Ferreira A.; Morello A.; Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian host. Comp Biochem Physiol A Mol Integr Physiol  2007,146(4),601-620","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.fitote.2015.06.007","volume":"105","author":"Cretton S.","year":"2015","unstructured":"Cretton S.; Br\u00e9ant L.; Pourrez L.; Ambuehl C.; Perozzo R.; Marcourt L.; Kaiser M.; Cuendet M.; Christen P.; Chemical constituents from Waltheria indica exert in vitro activity against Trypanosoma brucei and T. cruzi. Fitoterapia  2015,105,55-60","journal-title":"Fitoterapia"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1021\/np800377y","volume":"72","author":"Trevisan G.","year":"2009","unstructured":"Trevisan G.; Maldaner G.; Velloso N.A.; Sant\u2019Anna G.S.; Ilha V.; Velho Gewehr C.C.; Rubin M.A.; Morel A.F.; Ferreira J.; Antinociceptive effects of 14-membered cyclopeptide alkaloids. J Nat Prod  2009,72(4),608-612","journal-title":"J Nat Prod"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.actatropica.2012.11.014","volume":"125","author":"Veiga-Santos P.","year":"2013","unstructured":"Veiga-Santos P.; Desoti V.C.; Miranda N.; Ueda-Nakamura T.; Dias-Filho B.P.; Silva S.O.; Cortez D.A.G.; de Mello J.C.P.; Nakamura C.V.; The natural compounds piperovatine and piperlonguminine induce autophagic cell death on Trypanosoma cruzi. Acta Trop  2013,125(3),349-356","journal-title":"Acta Trop"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1021\/np800294q","volume":"71","author":"Pontius A.","year":"2008","unstructured":"Pontius A.; Krick A.; Kehraus S.; Brun R.; K\u00f6nig G.M.; Antiprotozoal activities of heterocyclic-substituted xanthones from the marine-derived fungus Chaetomium sp. J Nat Prod  2008,71(9),1579-1584","journal-title":"J Nat Prod"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"11146","DOI":"10.3390\/molecules170911146","volume":"17","author":"Mart\u00ednez-Luis S.","year":"2012","unstructured":"Mart\u00ednez-Luis S.; G\u00f3mez J.F.; Spadafora C.; Guzm\u00e1n H.M.; Guti\u00e9rrez M.; Antitrypanosomal alkaloids from the marine bacterium Bacillus pumilus. Molecules  2012,17(9),11146-11155","journal-title":"Molecules"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.tet.2010.11.103","volume":"67","author":"Regalado E.L.","year":"2011","unstructured":"Regalado E.L.; Jim\u00e9nez-Romero C.; Genta-Jouve G.; Tasdemir D.; Amade P.; Nogueiras C.; Thomas O.P.; Acanthifoliosides, minor steroidal saponins from the Caribbean sponge Pandaros acanthifolium. Tetrahedron  2011,67(5),1011-1018","journal-title":"Tetrahedron"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1016\/j.bmc.2007.07.032","volume":"15","author":"Tasdemir D.","year":"2007","unstructured":"Tasdemir D.; Topaloglu B.; Perozzo R.; Brun R.; O\u2019Neill R.; Carballeira N.M.; Zhang X.; Tonge P.J.; Linden A.; R\u00fcedi P.; Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli. Bioorg Med Chem  2007,15(21),6834-6845","journal-title":"Bioorg Med Chem"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1021\/np0605790","volume":"70","author":"Linington R.G.","year":"2007","unstructured":"Linington R.G.; Gonz\u00e1lez J.; Ure\u00f1a L.D.; Romero L.I.; Ortega-Barr\u00eda E.; Gerwick W.H.; Venturamides A and B: antimalarial constituents of the panamanian marine Cyanobacterium Oscillatoria sp. J Nat Prod  2007,70(3),397-401","journal-title":"J Nat Prod"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1246\/bcsj.59.2495","volume":"59","author":"Wu H.","year":"1986","unstructured":"Wu H.; Nakamura H.; Kobayashi J.; Kobayashi M.; Ohizumi Y.; Hirata Y.; Structures of agelasines, diterpenes having a 9-methyladeninium chromophore isolated from the okinawan marine sponge Agelas nakamurai Hoshino. Bull Chem Soc Jpn  1986,59(8),2495-2504","journal-title":"Bull Chem Soc Jpn"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3109\/14756366.2012.668539","volume":"28","author":"Assis D.M.","year":"2013","unstructured":"Assis D.M.; Gontijo V.S.; de Oliveira Pereira I.; Santos J.A.N.; Camps I.; Nagem T.J.; Ellena J.; Izidoro M.A.; dos Santos Tersariol I.L.; de Barros N.M.T.; Doriguetto A.C.; dos Santos M.H.; Juliano M.A.; Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor. J Enzyme Inhib Med Chem  2013,28(4),661-670","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1021\/np0705256","volume":"71","author":"Kossuga M.H.","year":"2008","unstructured":"Kossuga M.H.; Nascimento A.M.; Reim\u00e3o J.Q.; Tempone A.G.; Taniwaki N.N.; Veloso K.; Ferreira A.G.; Cavalcanti B.C.; Pessoa C.; Moraes M.O.; Mayer A.M.S.; Hajdu E.; Berlinck R.G.S.; Antiparasitic, antineuroinflammatory, and cytotoxic polyketides from the marine sponge Plakortis angulospiculatus collected in Brazil. J Nat Prod  2008,71(3),334-339","journal-title":"J Nat Prod"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1021\/jm0110892","volume":"45","author":"Wright A.D.","year":"2002","unstructured":"Wright A.D.; Goclik E.; K\u00f6nig G.M.; Kaminsky R.; Lepadins D-F: antiplasmodial and antitrypanosomal decahydroquinoline derivatives from the tropical marine tunicate Didemnum sp. J Med Chem  2002,45(14),3067-3072","journal-title":"J Med Chem"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ijantimicag.2010.07.003","volume":"36","author":"Astelbauer F.","year":"2010","unstructured":"Astelbauer F.; Obwaller A.; Raninger A.; Brem B.; Greger H.; Duch\u00eane M.; Wernsdorfer W.; Walochnik J.; High antitrypanosomal activity of plant-derived sulphur-containing amides. Int J Antimicrob Agents  2010,36(6),570-572","journal-title":"Int J Antimicrob Agents"},{"key":"ref=150","first-page":"1","volume":"2013","author":"Frank F.M.","year":"2013","unstructured":"Frank F.M.; Ulloa J.; Cazorla S.I.; Maravilla G.; Malchiodi E.L.; Grau A.; Martino V.; Catal\u00e1n C.; Muschietti L.V.; Trypanocidal activity of Smallanthus Sonchifolius: Identification of active sesquiterpene lactones by bioassay-guided fractionation. Evid Based Complement Alternat Med  2013,2013,1-8","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bmcl.2009.11.040","volume":"20","author":"Moon J.T.","year":"2010","unstructured":"Moon J.T.; Ha S.H.; Lee S.H.; Kwon T.H.; Oh C.R.; Kim Y.D.; Kim J.; Choo D.J.; Lee J.Y.; Total synthesis and biological evaluation of methylgerambullone. Bioorg Med Chem Lett  2010,20(1),52-55","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1021\/np9604238","volume":"59","author":"Greger H.","year":"1996","unstructured":"Greger H.; Zechner G.; Hofer O.; Vajrodaya S.; Bioactive amides from Glycosmis species. J Nat Prod  1996,59(12),1163-1168","journal-title":"J Nat Prod"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/md8010047","volume":"8","author":"Orhan I.","year":"2010","unstructured":"Orhan I.; \u015eener B.; Kaiser M.; Brun R.; Tasdemir D.; Inhibitory activity of marine sponge-derived natural products against parasitic protozoa. Mar Drugs  2010,8(1),47-58","journal-title":"Mar Drugs"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.3390\/md11104058","volume":"11","author":"Jones A.","year":"2013","unstructured":"Jones A.; Grkovic T.; Sykes M.; Avery V.; Trypanocidal activity of marine natural products. Mar Drugs  2013,11(10),4058-4082","journal-title":"Mar Drugs"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/1568026623666230123142357","volume":"23","author":"Nandi S.","year":"2023","unstructured":"Nandi S.; Chauhan B.; Tarannum H.; Khede M.K.; Multi-target polypharmacology of 4-aminoquinoline compounds against malaria, tuberculosis and cancer. Curr Top Med Chem  2023,23(5),403-414","journal-title":"Curr Top Med Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jep.2007.12.018","volume":"116","author":"Rodrigues Silva D.","year":"2008","unstructured":"Rodrigues Silva D.; Baroni S.; Svidzinski A.E.; Bersani-Amado C.A.; Cortez D.A.G.; Anti-inflammatory activity of the extract, fractions and amides from the leaves of Piper ovatum Vahl (Piperaceae). J Ethnopharmacol  2008,116(3),569-573","journal-title":"J Ethnopharmacol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/molecules14010279","volume":"14","author":"Vik A.","year":"2009","unstructured":"Vik A.; Proszeny\u00e1k \u00c1.; Vermeersch M.; Cos P.; Maes L.; Gundersen L.L.; Screening of agelasine D and analogs for inhibitory activity against pathogenic protozoa; identification of hits for visceral leishmaniasis and Chagas disease. Molecules  2009,14(1),279-288","journal-title":"Molecules"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673311070240807104229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233416\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673311070240807104229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:50:51Z","timestamp":1791877851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233416\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":157,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673311070240807104229","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}